Complete Omics Inc. Complete Omics Inc. Complete Omics Inc. Complete Omics Inc.
  • Home
  • About
    • Our Impact
    • Our Team
  • Clinical
    • Column

      Clinical Multi-Omics

      • Clinical Proteomics
        • There is a lot more to be offered, secret for now…
      • Clinical Multi-Omics Molecular Diagnostics
        • There is a lot more to be offered, secret for now…

      Our Latest News In Clinical Applications

      Detecting and Absolutely Quantifying Patient-specific Neoantigens from Limited Input of Biopsy Sample — An Integrated Pipeline for Neoantigen-targeted Cancer Treatments

      February 28, 2022
      Read More »

      Identifying and Quantifying Neoantigens derived from Human endogenous retroviruses (HERVs) — A new class of targets to expand the benefits of cancer immunotherapy.

      January 29, 2022
      Read More »

      Our clinical proteomics pipeline enabling personalized cancer therapeutics, reported by numerous media

      March 15, 2021
      Read More »
  • Research
    • Column

      Proteomics

      • Qualitative Proteomics
        • Proteome Profiling
        • De novo Antibody Sequencing
        • Protein Identification and Mapping
      • PTM Proteomics
        • PhosphoProteomics
        • GlycoProteomics
        • Other PTMS
      • Immunoprecipitated Profiling and Quantification

        

      • Quantitative Proteomics
        • TMT, iTRAQ, SILAC and other Label-dependent Quantification
        • SRM / MRM / PRM Absolute Quantification
        • Label-free Quantification
      • Specialized Services
        • Valid-NEO: Neoantigen Direct Observation
        • Host Cell Protein Analysis

      Genomics

      • Damaged Sample NGS
        • FFPE, Plasma, Fossil, Ancient and Damaged Sample
        • ChIP-Seq
        • Single Cell Sequencing
        • Methyl-Seq
      • Conventional NGS
        • Genome / Exome-Seq, Targeted Seq, RNA-Seq

      Metabolomics

      • Targeted Metabolomics
        • Targeted detection and quantification of vitamins, amino acids, hormones and 3,000+ kinds of small molecules
      • Untargeted Metabolomics
        • Complete profiling of water/lipid-soluble metabolite molecules
      • Lipidomics (ID and Quant)

      Single Cell Omics

      • Single Cell Proteomics
        • Antibody-independent Single Cell Proteomics Assays — Profiling Assay and Targeted Detection
      • Single Cell Genomics
        • Single Cell RNA-Seq and Genomics Assay — Signaling Pathway Assays and Genomic Changes
      • — All single cell services are conducted by leading experts through singlecell.com —

      Select Notable Projects

      List of Notable Projects
      Page1 Page2 Page3
  • News
  • Contact

Blog Grid

  • Collaboration with Columbia University

    March 30, 2022

    Mar 30, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Kam W. Leong, Samuel Y. Sheng professor of Biomedical Engineering, and his team from…

  • Collaboration with Tel Aviv University

    March 20, 2022

    Mar 20, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Miguel Weil from Department of Cell Research and Immunology at the Tel Aviv University…

  • Detecting and Absolutely Quantifying Patient-specific Neoantigens from Limited Input of Biopsy Sample — An Integrated Pipeline for Neoantigen-targeted Cancer Treatments

    February 28, 2022

    Neoantigens derived from HERVs represent a new group of cancer therapeutic targets. In a collaborating project, Complete Omics identified and quantified HERVs derived neoantigens and provided solid evidence for developing…

  • Collaboration with Lisbon School of Medicine

    February 26, 2022

    Feb 26, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Dr. Luis Marques da Costa and his team from Lisbon School of Medicine on a…

  • Collaboration with University of Utah Huntsman Cancer Institute

    February 7, 2022

    Feb 07, 2022 | BALTIMORE –  Complete Omics’ Clinical Proteomics team announced a collaboration with Professor Sumati Gupta and her team from University of Utah Huntsman Cancer Institute on a clinical…

About Complete Omics

Complete Omics — making OMICS-based clinical care a reality.

We are on Twitter

  • Identifying and Quantifying Neoantigens derived from Human endogenous retroviruses (HERVs) — A new class of targets… https://t.co/jMIgXUQ7dZ 1 year ago
  • https://t.co/T6hJY3bEkZ https://t.co/lAbMY8INWJ 2 years ago
Follow @completeomics

News

  • Collaboration with Columbia University
    March 30, 2022
  • Collaboration with Tel Aviv University
    March 20, 2022

All Rights Reserved

  • Payment Terms
  • Privacy Policy

Your ticket for the: Blog Grid

Title

Blog Grid

USD

Follow by Email
Facebook
Twitter
LinkedIn